| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From Medizinische Klinik, Munich, Republic of Germany
2 From Klinik fur Strahlentherapie und Radionnokologie, Munich, Republic of Germany
3 From Klinikum Innenstadt Zentralkrancenhaus Gauting, Munich, Republic of Germany
4 From Zusamklinik, LVA, Munich, Republic of Germany
Aim of the study: Remote high dose rate brachytherapy is an effective local treatment modality for central lung tumors and has the potential to improve survival time. Optimal dose and fractionation schemes have not been identified yet. We conducted a prospective randomized study to compare two treatment schedules in terms of survival time, local tumor control, and possible complications.
Design: Group 1 received 4 brachytherapies with a dose of 3.8 Gy (at a 10-mm depth) on a weekly basis, and group 2 received 2 treatments with 7.2 Gy (at a 10-mm depth) at a 3-week interval. At a depth of 5 mm, the calculated doses would be 8 and 15 Gy. This study is still ongoing. Here we report interim results.
Patients: Ninety-three patients with advanced cancer were included in the study; 44 were in group 1 and 49, in group 2. Both groups were comparable regarding age, sex, tumor stage, Karnofsky performance status, and histologic findings.
Interventions: A mean total irradiation dose of 13.4±5.2 Gy for group 1 and 13.7±4.4 for group 2 were applied (calculated at 10 mm from the source axis, equivalent to 27.9 Gy in group 1 and 28.5 Gy in group 2 at a 5-mm depth).
Results: The 1-year survival rate was 11.4% in group 1 and 20.4% in group 2. No significant difference in survival time was found, but mean survival was longer in group 2 (49 weeks) than in group 1 (26 weeks). Local control after 3 months was comparable in both groups. Fatal hemoptysis occurred at a similar rate in group 1 (22.2%) and in group 2 (21.1%).
Conclusion: High-dose rate brachytherapy with 2x7.2 Gy with a 3-week interval is equivalent to a 4x3.8-Gy regimen on a weekly basis. The shorter treatment schedule is more convenient for patients, does not cause more side effects, and provides an equal local tumor control.
Key Words: lung neoplasm radiotherapy • brachytherapy • prospective studies • survival analysis
Submitted on October 21, 1993
Accepted on July 21, 1994
This article has been cited by other articles:
|
|
 |
|
  J-M. Vergnon, R. M. Huber, and K. Moghissi Place of cryotherapy, brachytherapy and photodynamic therapy in therapeutic bronchoscopy of lung cancers. Eur. Respir. J., July 1, 2006; 28(1): 200 - 218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.A. Escobar-Sacristan, J.I. Granda-Orive, T. Gutierrez Jimenez, J.M. Delgado, A. Rodero Banos, and R. Saez Valls Endobronchial brachytherapy in the treatment of malignant lung tumours Eur. Respir. J., September 1, 2004; 24(3): 348 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Kvale, M. Simoff, and U. B. S. Prakash Palliative Care Chest, January 1, 2003; 123(1_suppl): 284S - 311S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Celebioglu, O. U. Gurkan, S. Erdogan, I. Savas, K. Kose, C. Kurtman, and U. Gonullu High Dose Rate Endobronchial Brachytherapy Effectively Palliates Symptoms Due to Inoperable Lung Cancer Jpn. J. Clin. Oncol., November 1, 2002; 32(11): 443 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Muto, V. Ravo, G. Panelli, G. Liguori, and G. Fraioli High-Dose Rate Brachytherapy of Bronchial Cancer: Treatment Optimization Using Three Schemes of Therapy Oncologist, June 1, 2000; 5(3): 209 - 214. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. Wassermann, H.-E. Eckel, O. Michel, and R.-P. Muller EMERGENCY STENTING OF MALIGNANT OBSTRUCTION OF THE UPPER AIRWAYS: LONG-TERM FOLLOW-UP WITH TWO TYPES OF SILICONE PROSTHESES J. Thorac. Cardiovasc. Surg., October 1, 1996; 112(4): 859 - 866. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
